Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Yan Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2065-0070; OpenAlex author ID A5101545112. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper

Papers 1

  1. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. Co-author DOI 10.15252/embj.2023114558↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junpeng Meng · 1 shared paper, 2023 · strength 0.19
  2. Taoyu Chen · 1 shared paper, 2023 · strength 0.19
  3. Feng Guo · 1 shared paper, 2023 · strength 0.19
  4. Heshui Wu · 1 shared paper, 2023 · strength 0.19
  5. Xin Jin · 1 shared paper, 2023 · strength 0.19
  6. Dianyun Ren · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.